# Denosumab for Breast Cancer With Bone Mets

> **NCT01952054** · PHASE2 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 7 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Denosumab

## Key facts

- **NCT ID:** NCT01952054
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02-09
- **Primary completion:** 2018-10-10
- **Final completion:** 2018-10-10
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2019-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01952054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01952054, "Denosumab for Breast Cancer With Bone Mets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01952054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*